Thomas S K Gilbert

7PUBLICATIONS
28CO-AUTHORS
Molecular targetsMedical virologyBiomolecular modelling and designHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2023
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals.

Ethan J Fritch, Angie L Mordant, Thomas S K Gilbert

|Oct 26, 2022
Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latency.

Amanda B Wass, Benjamin A Krishna, Laura E Herring

|Jul 25, 2022
Correction to "Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues".

Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell

|Sep 10, 2019
Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology.

Chenxiao Da, Dehui Zhang, Michael Stashko

|Jul 18, 2019
Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.

Devon R Blake, Angelina V Vaseva, Richard G Hodge

|Apr 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues.

Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell

Pageof 2